The funding is being provided by three charities under a program designed to facilitate collaboration between research groups from different institutions.
The company said the NIH funding will enable it to further validate the saliva-based test and prepare it for commercial launch later this year.
The company will use the funds to develop and refine proprietary algorithms for identifying more complex variants including translocations and inversions.
The appropriations package would boost the NIH's fiscal 2019 budget to $39.1 billion, and earmarks money for programs such as the All of Us initiative.
The firm will use the funds to advance its high-throughput single-cell analysis platform to analyze heterogeneity in cell populations for research and drug discovery.
UMich's Arul Chinnaiyan plans to use the funding to develop new tools and technologies to identify biomarkers for cancer diagnosis and treatment.
The assay will combine the company's CytoSort assay with its automated AIR system for imaging, sorting, and isolating single cells and small colonies.
The researchers are studying the molecular links between bile duct cancer and liver fluke infection, and testing a vaccine to protect against infection.
The program was established to support the development and dissemination of functional genomic tools and techniques for genome manipulation in model organisms.
The project aims to use circulating tumor DNA to monitor drug response and resistance in metastatic melanoma patients in order to guide treatment decisions.
UCSD plans to expand the Metabolomics Workbench to include a wide range of clinical trials data including demographics and trial protocols.
The bill, which will go before the House later this year, includes a 5.4 percent increase in National Institutes of Health funding to $39.1 billion.
Investigators from the school will use the funding to continue a research program applying genomics to hearing loss screening and treatment.
The system is designed to detect single amino acid polymorphisms in touch skin samples that can be used to identify specific people.
The Genome Canada program will encourage the formation of private-public partnerships to develop gene-based technologies for healthcare and agriculture.
The groups will conduct a study evaluating the benefits of targeted next-generation sequencing in the diagnosis and care of infants with genetic disorders.
The automated, whole-genome directional genomic hybridization system can measure de novo random, low-frequency, and complex structural variations.
As part of an NIH SBIR grant, Genomenon is automating the curation of medical literature in its Mastermind variant interpretation software.
The grants are designed to help investigators working within groups pursue independent research and advance their careers in genomic science.
The test uses changes in DNA methylation patterns for the early detection of lung cancer and is based on the same platform as the firm's bladder cancer test.
Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.
The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.
UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.
In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.